Standardizing Naloxone Co-Prescription to Promote Harm Reduction in Pediatric Sickle Cell Pain Management

Presenter Information

• Nali Gillepsie MD, LSU
• Morgan Viviano MD
• Alexis Brantley MD
• Leah Smith DO
• Ushma Bhandary MD
• Dana LeBlanc MD
• Molly Sonenklar MD

Presentation Type

Presentation

Location

Lions Eye Center, LSUHSC-NO

Start Date

29-5-2025 1:15 PM

End Date

29-5-2025 2:45 PM

Comments

Winner: Best Oral Presentation

The attached document has been formatted to meet PDF/UA v1 - ISO 14289-1 2014 accessibility compliance standards. Please contact DigitalScholar@lsuhsc.edu if further assistance is needed.

Recommended Citation

Gillepsie, Nali MD; Viviano, Morgan MD; Brantley, Alexis MD; Smith, Leah DO; Bhandary, Ushma MD; LeBlanc, Dana MD; and Sonenklar, Molly MD, "Standardizing Naloxone Co-Prescription to Promote Harm Reduction in Pediatric Sickle Cell Pain Management" (2025). Quality Improvement & Patient Safety Forum. 7.
https://digitalscholar.lsuhsc.edu/qi_forum/2025/presentations/7